These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 33933722)

  • 1. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study.
    Laupsa-Borge J; Grytten E; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Front Nutr; 2023; 10():1020678. PubMed ID: 37404855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.
    Skulas-Ray AC; Alaupovic P; Kris-Etherton PM; West SG
    J Clin Lipidol; 2015; 9(3):360-7. PubMed ID: 26073395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
    Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
    Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
    Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
    Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects.
    Finnegan YE; Minihane AM; Leigh-Firbank EC; Kew S; Meijer GW; Muggli R; Calder PC; Williams CM
    Am J Clin Nutr; 2003 Apr; 77(4):783-95. PubMed ID: 12663273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of dietary ω-6 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial.
    Drouin-Chartier JP; Tremblay AJ; Lépine MC; Lemelin V; Lamarche B; Couture P
    Am J Clin Nutr; 2018 Jan; 107(1):26-34. PubMed ID: 29381796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial.
    Dogay Us G; Mushtaq S
    Lipids Health Dis; 2022 Sep; 21(1):84. PubMed ID: 36050695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
    Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
    Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults.
    Moosavi D; Vuckovic I; Kunz HE; Lanza IR
    J Nutr; 2022 Jul; 152(7):1675-1689. PubMed ID: 35389487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
    Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
    Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.
    Caslake MJ; Miles EA; Kofler BM; Lietz G; Curtis P; Armah CK; Kimber AC; Grew JP; Farrell L; Stannard J; Napper FL; Sala-Vila A; West AL; Mathers JC; Packard C; Williams CM; Calder PC; Minihane AM
    Am J Clin Nutr; 2008 Sep; 88(3):618-29. PubMed ID: 18779276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial.
    Deck C; Radack K
    Arch Intern Med; 1989 Aug; 149(8):1857-62. PubMed ID: 2669667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women.
    Moore CS; Bryant SP; Mishra GD; Krebs JD; Browning LM; Miller GJ; Jebb SA
    Nutrition; 2006 Oct; 22(10):1012-24. PubMed ID: 17027436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT).
    Senanayake VK; Pu S; Jenkins DA; Lamarche B; Kris-Etherton PM; West SG; Fleming JA; Liu X; McCrea CE; Jones PJ
    Trials; 2014 Apr; 15():136. PubMed ID: 24754911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes.
    Hilpert KF; West SG; Kris-Etherton PM; Hecker KD; Simpson NM; Alaupovic P
    Am J Clin Nutr; 2007 Feb; 85(2):369-76. PubMed ID: 17284731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.